UPDATE: Roth Capital Downgrades Conatus Pharmaceuticals (CNAT) to Neutral Mar 26, 2019 08:08AM
Conatus Pharmaceuticals to Participate in Upcoming Investor Conferences Sep 19, 2018 07:30AM
Conatus Pharmaceuticals to Highlight Anticipated Clinical Data Readouts at Upcoming Investor Conferences Mar 5, 2018 07:30AM
Conatus Pharmaceuticals to Host Expert Call on Unmet Need in HCV-SVR Patients Feb 12, 2018 07:30AM
Roth Capital Starts Conatus Pharmaceuticals (CNAT) at Buy, 'High Ambitions, High Reward' Feb 8, 2018 08:49AM


Jan 6, 2016 09:26AM Roth Capital Reiterates Buy Following Conatus Pharmaceuticals (CNAT) Phase II Emricasan Data
Sep 24, 2015 06:46AM Conatus Pharmaceuticals (CNAT) Bullish Stance Reiterated at Roth Capital Following Data
Apr 8, 2015 04:01PM Conatus Announces Completion of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Apr 8, 2015 04:01PM Conatus Announces Completion of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Apr 2, 2015 09:02AM Conatus Pharmaceuticals (CNAT) Prices 3.5M Common Offering at $5.75/Share
Apr 2, 2015 09:00AM Conatus Announces Pricing of Public Offering of Common Stock
Apr 2, 2015 09:00AM Conatus Announces Pricing of Public Offering of Common Stock
Apr 1, 2015 04:51PM Conatus Pharmaceuticals (CNAT) Falls on Plans to Offer Common Stock
Apr 1, 2015 04:01PM Conatus Announces Proposed Public Offering of Common Stock
Apr 1, 2015 04:01PM Conatus Announces Proposed Public Offering of Common Stock
Mar 17, 2015 09:20AM Roth Capital Reinstates Conatus Pharmaceuticals (CNAT) at Buy
Jun 20, 2014 01:04PM Unusual 11 Mid-Day Movers 06/20: (KMX) (FLML) (CARA) Higher; (MACK) (PVCT) (CLRX) Lower
Jun 13, 2014 09:30AM Pre-Open Stock Movers 6/13: (OPEN) (EXPR) (ICLD) Higher; (FNSR) (OCLS) (ETRM) Lower (more...)
Jun 13, 2014 09:22AM Roth Capital Starts Conatus Pharmaceuticals (CNAT) at Buy
Mar 7, 2014 10:45AM Notable Analyst Rating Changes 03/07: (GTAT) (CCRN) (PRU) Upgraded; (ALU) (NMRX) (VMEM) Downgraded
Mar 7, 2014 06:50AM Roth Capital Starts Conatus Pharmaceuticals (CNAT) at Buy